Ginsenoside Rg5 is the main component of Red ginseng and IGF-1R agonist. Ginsenoside Rg5 compets for the binding site of IGF-1R and blocks the binding of IGF-1 to IGF-1R (IC50 about 90 nM). Ginsenoside Rg5 also inhibits the mRNA expression of COX-2 via suppression of the DNA binding activities of NF-κB p65. Ginsenoside Rg5 是 IGF-1R 激动剂。

rg5属于美标锡青铜合金。 其对应中国GB牌号为ZCuSn5Pb5Zn5;对应国际ISO牌号为CUPB5SN5ZN5;对应原苏联гOCT牌号为BPO5ц5C5;对应日本JIS牌号为BC6;对应德国DIN牌号为G-CuSn5ZnPb;对应英国BS牌号为LG2;对应法国NF牌号为CuPb5Sn5Zn5。

Ginsenoside Rg5 (Rg5) is a minor ginsenoside synthesized during ginseng steaming treatment that exhibits superior pharmaceutical activity compared with major ginsenosides. With high safety and various biological functions, Rg5 may act as a potential therapeutic candidate for …

2022年12月2日 · RG5 coaxial cables are designed for high-speed data transmission over medium to long distances. They are often used in the data transmission environment for communications applications such as voice, video, and data.

Ginsenoside Rg5 is a triterpenoid saponin. It has a role as a metabolite. Ginsenoside Rg5 has been reported in Panax notoginseng and Centella asiatica with data available.

2023年10月29日 · Ginsenoside Rg5, a relatively uncommon secondary ginsenoside, exhibits notable pharmacological activity and is commonly hypothesized to originate from the dehydration of Rg3. In this work, we compared different conversion pathways using Rb1, R -Rg3 and S -Rg3 as the raw material under simple acid catalysis.

Ginsenoside Rg5 (G-Rg5) is a rare ginsenoside isolated from ginseng (Panax ginseng C.A. Meyer), and this compound is increasingly known for its potent pharmacological activities. This study aimed to provide a comprehensive review of the main activities and mechanisms of G-Rg5 by adopting network pharmacological analysis combined with a summary ...

人参皂苷Rg5通过抑制脂多糖(LPS)刺激的BV2小神经胶质细胞中NF-κBp65的DNA结合活性来抑制COX-2的mRNA表达。 Rg5预处理组小鼠显示NF-κBp65和COX-2的表达下降。在用低剂量的人参皂苷Rg5(10mg/kg)治疗的组中,存在显着的肾小管损伤和炎性细胞的浸润。

Ginsenoside Rg5 is the main component of Red ginseng and IGF-1R agonist. Ginsenoside Rg5 compets for the binding site of IGF-1R and blocks the binding of IGF-1 to IGF-1R (IC50 about 90 nM). Ginsenoside Rg5 also inhibits the mRNA expression of COX-2 via suppression of the DNA binding activities of NF-κB p65.

人参皂苷 Rg5 (Rg5) 是一种仅从人参物种中提取的次要人参皂苷成分，以其广谱药理活性而闻名。 本文旨在全面综述 Rg5 的抗癌特性，重点关注作用机制、构效关系 (SAR) 和药代动力学属性。